SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-07-005875
Filing Date
2007-03-16
Accepted
2007-03-16 06:02:40
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a28242e10vk.htm 10-K 570310
2 EXHIBIT 10.53 a28242exv10w52.htm EX-10.52 20587
3 EXHIBIT 10.66 a28242exv10w66.htm EX-10.66 25911
4 EXHIBIT 23.1 a28242exv23w1.htm EX-23.1 2390
5 EXHIBIT 31.1 a28242exv31w1.htm EX-31.1 8619
6 EXHIBIT 31.2 a28242exv31w2.htm EX-31.2 8752
7 EXHIBIT 32.1 a28242exv32w1.htm EX-32.1 4535
8 GRAPHIC a28242a2824201.gif GRAPHIC 9800
  Complete submission text file 0000950134-07-005875.txt   656163
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24274 | Film No.: 07697935
SIC: 2836 Biological Products, (No Diagnostic Substances)